XIAP downregulation promotes caspase-dependent inhibition of proteasome activity in AML cells

Leukemia Research

Volumn 37, Issue 8, 2013, Pages 974-979

  Carter, Bing Z ^a   Mak, Duncan H ^a   Wang, Zhiqiang ^a   Ma, Wencai ^a   Mak, Po Yee ^a   Andreeff, Michael ^a   Davis, R Eric ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

AML; Caspase; Gene expression; I B ; Proteasome; XIAP

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BORTEZOMIB; CASPASE; HEAT SHOCK PROTEIN 70; I KAPPA B ALPHA; PROTEASOME; PROTEIN MCL 1; X LINKED INHIBITOR OF APOPTOSIS;

ACUTE GRANULOCYTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; DOWN REGULATION; DRUG TARGETING; ENZYME INHIBITION; GENE ACTIVITY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REPRESSION; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEASOME GENE; UPREGULATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; BORONIC ACIDS; CASPASES; CELL LINE, TUMOR; CELL SURVIVAL; DOWN-REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; HL-60 CELLS; HSP72 HEAT-SHOCK PROTEINS; HUMANS; I-KAPPA B PROTEINS; LEUKEMIA, MYELOID, ACUTE; LEUPEPTINS; OLIGONUCLEOTIDES, ANTISENSE; OLIGOPEPTIDES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTO-ONCOGENE PROTEINS C-BCL-2; PYRAZINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 84879786030     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2013.04.018     Document Type: Article

References (28)

1. Deveraux Q.L., Roy N., Stennicke H.R., Van A.T., Zhou Q., Srinivasula S.M., et al. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 1998, 17:2215-2223.
2. Shiozaki E.N., Chai J., Rigotti D.J., Riedl S.J., Li P., Srinivasula S.M., et al. Mechanism of XIAP-mediated inhibition of caspase-9. Mol Cell 2003, 11(2):519-527. [Epub 2003/03/07].
3. Deveraux Q.L., Takahashi R., Salvesen G.S., Reed J.C. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 1997, 388(6639):300-304.
4. Chai J., Shiozaki E., Srinivasula S.M., Wu Q., Datta P., Alnemri E.S., et al. Structural basis of caspase-7 inhibition by XIAP. Cell 2001, 104(5):769-780. [Epub 2001/03/21].
5. Riedl S.J., Renatus M., Schwarzenbacher R., Zhou Q., Sun C., Fesik S.W., et al. Structural basis for the inhibition of caspase-3 by XIAP. Cell 2001, 104(5):791-800. [Epub 2001/03/21].
6. Scott F.L., Denault J.B., Riedl S.J., Shin H., Renatus M., Salvesen G.S. XIAP inhibits caspase-3 and -7 using two binding sites: evolutionarily conserved mechanism of IAPs. EMBO J 2005, 24(3):645-655. [Epub 2005/01/15].
7. Resch U., Schichl Y.M., Sattler S., de Martin R. XIAP regulates intracellular ROS by enhancing antioxidant gene expression. Biochem Biophys Res Commun 2008, 375(1):156-161. [Epub 2008/08/12].
8. Levkau B., Garton K.J., Ferri N., Kloke K., Nofer J.R., Baba H.A., et al. xIAP induces cell-cycle arrest and activates nuclear factor-kappaB: new survival pathways disabled by caspase-mediated cleavage during apoptosis of human endothelial cells. Circ Res 2001, 88(3):282-290. [Epub 2001/02/17].
9. Rigaud S., Fondaneche M.C., Lambert N., Pasquier B., Mateo V., Soulas P., et al. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature. 2006, 444(7115):110-114. [Epub 2006/11/03].
10. Olayioye M.A., Kaufmann H., Pakusch M., Vaux D.L., Lindeman G.J., Visvader J.E. XIAP-deficiency leads to delayed lobuloalveolar development in the mammary gland. Cell Death Differ 2005, 12:87-90.
11. Birkey Reffey S., Wurthner J.U., Parks W.T., Roberts A.B., Duckett C.S. X-linked inhibitor of apoptosis protein functions as a cofactor in transforming growth factor-beta signaling. J Biol Chem 2001, 276(28):26542-26549. [Epub 2001/05/18].
12. Kaur S., Wang F., Venkatraman M., Arsura M. X-linked inhibitor of apoptosis (XIAP) inhibits c-Jun N-terminal kinase 1 (JNK1) activation by transforming growth factor beta1 (TGF-beta1) through ubiquitin-mediated proteosomal degradation of the TGF-beta1-activated kinase 1 (TAK1). J Biol Chem 2005, 280(46):38599-38608. [Epub 2005/09/15].
13. Mehrotra S., Languino L.R., Raskett C.M., Mercurio A.M., Dohi T., Altieri D.C. IAP regulation of metastasis. Cancer Cell 2010, 17(1):53-64. [Epub 2010/02/05].
14. Carter B.Z., Milella M., Tsao T., McQueen T., Schober W.D., Hu W., et al. Regulation and targeting of antiapoptotic XIAP in acute myeloid leukemia. Leukemia 2003.
15. Ma W., Wang M., Wang Z.Q., Sun L., Graber D., Matthews J., et al. Effect of long-term storage in TRIzol on microarray-based gene expression profiling. Cancer Epidemiol Biomarkers Prev 2010, 19(10):2445-2452.
16. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 1995, 57(1):289-300.
17. Eisen M.B., Spellman P.T., Brown P.O., Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998, 95(25):14863-14868. [Epub 1998/12/09].
18. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005, 102(43):15545-15550.
19. Jakt L.M., Cao L., Cheah K.S., Smith D.K. Assessing clusters and motifs from gene expression data. Genome Res 2001, 11(1):112-123. [Epub 2001/01/13].
20. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(-Delta Delta C) method. Methods 2001, 25(4):402-408.
21. Martin S., Reutelingsperger C., McGahon A., Rader J., van Schie R., LaFace D., et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and ABL. J Exp Med 1995, 182:1545-1556.
22. Radhakrishnan S.K., Lee C.S., Young P., Beskow A., Chan J.Y., Deshaies R.J. Transcription factor Nrf1 mediates the proteasome recovery pathway after proteasome inhibition in mammalian cells. Mol Cell 2010, 38(1):17-28.
23. Orlowski R.Z., Kuhn D.J. Proteasome inhibitors in cancer therapy: lessons from the first decade. Clin Cancer Res 2008, 14(6):1649-1657. [Epub 2008/03/19].
24. Gray D.C., Mahrus S., Wells J.A. Activation of specific apoptotic caspases with an engineered small-molecule-activated protease. Cell 2010, 142(4):637-646.
25. Adrain C., Creagh E., Cullen S., Martin S. Caspase-dependent inactivation of proteasome function during programmed cell death in drosophila and man. J Biol Chem 2004, 279(35):36923-36930. [Epub 2004/06/24].
26. Sun X.M., Butterworth M., MacFarlane M., Dubiel W., Ciechanover A., Cohen G.M. Caspase activation inhibits proteasome function during apoptosis. Mol Cell 2004, 14(1):81-93. [Epub 2004/04/08].
27. Carter B.Z., Mak D.H., Morris S.J., Borthakur G., Estey E., Byrd A.L., et al. XIAP antisense oligonucleotide (AEG35156) achieves target knockdown and induces apoptosis preferentially in CD34+38- cells in a phase 1/2 study of patients with relapsed/refractory AML. Apoptosis 2011, 16(1):67-74. [Epub 2010/10/13].
28. Guzman M.L., Neering S.J., Upchurch D., Grimes B., Howard D.S., Rizzieri D.A., et al. Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells. Blood 2001, 98(8):2301-2307.